Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB18567ExperimentalCell transplant therapies
B7-H3-specific chimeric antigen receptor T cells: Overview.
- Also known as
- allogeneic T cells genetically modified to express anti-B7-H3 chimeric antigen receptor (CAR) · Autologous chimeric antigen receptor (CAR) T cells targeting B7-H3 · chimeric antigen receptor (CAR) modified recombinant T cells targeting B7-H3
Which companies are running trials of B7-H3-specific chimeric antigen receptor T cells, in which indications and phases, and which of those programs are still active?